NutriStack
Berberine and Insulin Glargine, a caution.
Berberine has significant glucose-lowering activity through AMPK activation and stimulation of endogenous GLP-1 secretion. When combined with insulin glargine, the additive hypoglycemic effect creates a serious risk of severe hypoglycemia. Unlike oral diabetes medications that have some glucose-dependent action, insulin glargine provides continuous basal insulin regardless of blood glucose, making the combination particularly risky for precipitating low blood sugar episodes.
One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.
From the interaction database
What the row says.
Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.
At a glance
- Substances
- Berberine and Insulin Glargine
- Pair type
- Caution
- Evidence (highest tier)
- Moderate
- Source citations
- 2 sources
- Stack Score effect
- −5 to your Stack Score (per scored caution row).
- Scope
- Supplement × Prescription
- Last verified
- May 30, 2026
Caution · Moderate evidence
Caution
What is happening. Berberine has significant glucose-lowering activity through AMPK activation and stimulation of endogenous GLP-1 secretion. When combined with insulin glargine, the additive hypoglycemic effect creates a serious risk of severe hypoglycemia. Unlike oral diabetes medications that have some glucose-dependent action, insulin glargine provides continuous basal insulin regardless of blood glucose, making the combination particularly risky for precipitating low blood sugar episodes.
Mechanism. Berberine activates AMPK, increasing glucose uptake in muscle and adipose tissue, suppressing hepatic gluconeogenesis, and stimulating GLP-1 secretion from intestinal L-cells. Insulin glargine provides continuous basal insulin activity for 24 hours. The combined glucose-lowering through both insulin-dependent and insulin-independent pathways creates significant hypoglycemia risk.
Recommendation. Do NOT add berberine to insulin glargine therapy without direct supervision from your prescriber. If approved, implement intensive blood glucose monitoring (at least 4-6 times daily) during initiation. Insulin dose reduction may be necessary. Carry fast-acting glucose (glucose tablets, juice) at all times. Report any hypoglycemic episodes immediately.
Sources (2)
- Yin J et al. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712-717. PMID 18442638
- Asbaghi O, Ghanbari N, Shekari M et al.. The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials.. Clinical Nutrition ESPEN. 2020. PMID 32690176
Stack Score
How this pair moves the number.
Effect on the composite score
If both Berberine and Insulin Glargine are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).
The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.
Check your full routine
One pair was the worked example. NutriStack runs every pair in your stack at once.
Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.